Cargando…

Altered Body Composition and Increased Resting Metabolic Rate Associated with the Postural Instability/Gait Difficulty Parkinson's Disease Subtype

BACKGROUND: Weight loss in Parkinson's disease (PD) patients is a common but poorly understood manifestation. Several studies have reported that weight changes could be related to motor symptoms, drug side effects, dysphagia, depression, and/or dementia. Weight loss in PD is not a benign phenom...

Descripción completa

Detalles Bibliográficos
Autores principales: Femat-Roldán, Giovana, Gaitán Palau, María Andrea, Castilla-Cortázar, Inma, Elizondo Ochoa, Georgina, Moreno, Nancy Guadalupe, Martín-Estal, Irene, Jiménez Yarza, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103052/
https://www.ncbi.nlm.nih.gov/pubmed/32257099
http://dx.doi.org/10.1155/2020/8060259
_version_ 1783511969413726208
author Femat-Roldán, Giovana
Gaitán Palau, María Andrea
Castilla-Cortázar, Inma
Elizondo Ochoa, Georgina
Moreno, Nancy Guadalupe
Martín-Estal, Irene
Jiménez Yarza, Miguel
author_facet Femat-Roldán, Giovana
Gaitán Palau, María Andrea
Castilla-Cortázar, Inma
Elizondo Ochoa, Georgina
Moreno, Nancy Guadalupe
Martín-Estal, Irene
Jiménez Yarza, Miguel
author_sort Femat-Roldán, Giovana
collection PubMed
description BACKGROUND: Weight loss in Parkinson's disease (PD) patients is a common but poorly understood manifestation. Several studies have reported that weight changes could be related to motor symptoms, drug side effects, dysphagia, depression, and/or dementia. Weight loss in PD is not a benign phenomenon and it has several clinical and prognostic implications with increased morbidity and mortality. Thus, it is crucial to determine nutritional changes in PD patients in order to prevent malnutrition and improve their quality of life. OBJECTIVE: To compare body composition and resting metabolic rates between PD patients and controls. METHODS: A total of 64 PD patients and 52 controls were studied. The Hoehn-Yahr scale was used to determine the disease stage, clinical and epidemiological data were recorded from verbal questionnaire, Inbody S10® was used to collect corporal parameters, and FitMate system was used to assess the resting metabolic rate. RESULTS: No significant differences were found between both experimental groups in age, gender, height, cholesterol levels, and the presence of hypertension, diabetes, and hypo/hyperthyroidism. However, the PD group showed lower body fat mass, whole-body fat percentage, and greater resting metabolic rate compared to controls (p < 0.05), with no significant differences in musculoskeletal mass. Parkinson's disease postural instability/gait difficulty (PD-PIGD) subtype showed lower body fat parameters, increased fat-free mass, and higher resting metabolic rates. CONCLUSIONS: These results suggest that PD patients present an increased resting metabolic rate associated with the postural instability/gait difficulty PD subtype, allowing a selective decrease of body fat mass and not musculoskeletal mass. Of note, several disease-related factors may contribute to this weight loss in PD patients, being a complex and multifactorial consequence. Our findings could likely be one of the many contributing factors. However, present findings may further add to our understanding of the phenomenon of weight loss in patients with PD.
format Online
Article
Text
id pubmed-7103052
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-71030522020-04-02 Altered Body Composition and Increased Resting Metabolic Rate Associated with the Postural Instability/Gait Difficulty Parkinson's Disease Subtype Femat-Roldán, Giovana Gaitán Palau, María Andrea Castilla-Cortázar, Inma Elizondo Ochoa, Georgina Moreno, Nancy Guadalupe Martín-Estal, Irene Jiménez Yarza, Miguel Parkinsons Dis Clinical Study BACKGROUND: Weight loss in Parkinson's disease (PD) patients is a common but poorly understood manifestation. Several studies have reported that weight changes could be related to motor symptoms, drug side effects, dysphagia, depression, and/or dementia. Weight loss in PD is not a benign phenomenon and it has several clinical and prognostic implications with increased morbidity and mortality. Thus, it is crucial to determine nutritional changes in PD patients in order to prevent malnutrition and improve their quality of life. OBJECTIVE: To compare body composition and resting metabolic rates between PD patients and controls. METHODS: A total of 64 PD patients and 52 controls were studied. The Hoehn-Yahr scale was used to determine the disease stage, clinical and epidemiological data were recorded from verbal questionnaire, Inbody S10® was used to collect corporal parameters, and FitMate system was used to assess the resting metabolic rate. RESULTS: No significant differences were found between both experimental groups in age, gender, height, cholesterol levels, and the presence of hypertension, diabetes, and hypo/hyperthyroidism. However, the PD group showed lower body fat mass, whole-body fat percentage, and greater resting metabolic rate compared to controls (p < 0.05), with no significant differences in musculoskeletal mass. Parkinson's disease postural instability/gait difficulty (PD-PIGD) subtype showed lower body fat parameters, increased fat-free mass, and higher resting metabolic rates. CONCLUSIONS: These results suggest that PD patients present an increased resting metabolic rate associated with the postural instability/gait difficulty PD subtype, allowing a selective decrease of body fat mass and not musculoskeletal mass. Of note, several disease-related factors may contribute to this weight loss in PD patients, being a complex and multifactorial consequence. Our findings could likely be one of the many contributing factors. However, present findings may further add to our understanding of the phenomenon of weight loss in patients with PD. Hindawi 2020-03-17 /pmc/articles/PMC7103052/ /pubmed/32257099 http://dx.doi.org/10.1155/2020/8060259 Text en Copyright © 2020 Giovana Femat-Roldán et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Femat-Roldán, Giovana
Gaitán Palau, María Andrea
Castilla-Cortázar, Inma
Elizondo Ochoa, Georgina
Moreno, Nancy Guadalupe
Martín-Estal, Irene
Jiménez Yarza, Miguel
Altered Body Composition and Increased Resting Metabolic Rate Associated with the Postural Instability/Gait Difficulty Parkinson's Disease Subtype
title Altered Body Composition and Increased Resting Metabolic Rate Associated with the Postural Instability/Gait Difficulty Parkinson's Disease Subtype
title_full Altered Body Composition and Increased Resting Metabolic Rate Associated with the Postural Instability/Gait Difficulty Parkinson's Disease Subtype
title_fullStr Altered Body Composition and Increased Resting Metabolic Rate Associated with the Postural Instability/Gait Difficulty Parkinson's Disease Subtype
title_full_unstemmed Altered Body Composition and Increased Resting Metabolic Rate Associated with the Postural Instability/Gait Difficulty Parkinson's Disease Subtype
title_short Altered Body Composition and Increased Resting Metabolic Rate Associated with the Postural Instability/Gait Difficulty Parkinson's Disease Subtype
title_sort altered body composition and increased resting metabolic rate associated with the postural instability/gait difficulty parkinson's disease subtype
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103052/
https://www.ncbi.nlm.nih.gov/pubmed/32257099
http://dx.doi.org/10.1155/2020/8060259
work_keys_str_mv AT fematroldangiovana alteredbodycompositionandincreasedrestingmetabolicrateassociatedwiththeposturalinstabilitygaitdifficultyparkinsonsdiseasesubtype
AT gaitanpalaumariaandrea alteredbodycompositionandincreasedrestingmetabolicrateassociatedwiththeposturalinstabilitygaitdifficultyparkinsonsdiseasesubtype
AT castillacortazarinma alteredbodycompositionandincreasedrestingmetabolicrateassociatedwiththeposturalinstabilitygaitdifficultyparkinsonsdiseasesubtype
AT elizondoochoageorgina alteredbodycompositionandincreasedrestingmetabolicrateassociatedwiththeposturalinstabilitygaitdifficultyparkinsonsdiseasesubtype
AT morenonancyguadalupe alteredbodycompositionandincreasedrestingmetabolicrateassociatedwiththeposturalinstabilitygaitdifficultyparkinsonsdiseasesubtype
AT martinestalirene alteredbodycompositionandincreasedrestingmetabolicrateassociatedwiththeposturalinstabilitygaitdifficultyparkinsonsdiseasesubtype
AT jimenezyarzamiguel alteredbodycompositionandincreasedrestingmetabolicrateassociatedwiththeposturalinstabilitygaitdifficultyparkinsonsdiseasesubtype